Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophageal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06469944
What this trial is testing

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Who this might be right for
Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more
Merck Sharp & Dohme LLC 160
Early research (Phase 1)Study completedNCT01927965
What this trial is testing

Study of Minnelide™ in Patients With Advanced GI Tumors

Who this might be right for
Advanced Gastrointestinal Tumors
Minneamrita Therapeutics LLC 45
Large-scale testing (Phase 3)Study completedNCT03143153
What this trial is testing

Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 970
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Large-scale testing (Phase 3)Study completedNCT02569242
What this trial is testing

Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer

Who this might be right for
Esophageal Cancer
Ono Pharmaceutical Co., Ltd. 419
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Large-scale testing (Phase 3)Not Yet RecruitingNCT07246330
What this trial is testing

Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tianjin Medical University Cancer Institute and Hospital 340
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06745193
What this trial is testing

A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Carcinoma
Peking University 63
Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Not applicableWithdrawnNCT06702384
What this trial is testing

Molecular Analysis of Gastric and OEsophageal Cancers STudy

Who this might be right for
Adenocarcinoma EsophagusAdenocarcinoma of the StomachAdenocarcinoma - GEJ+1 more
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)UnknownNCT04229849
What this trial is testing

Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 164
Early research (Phase 1)Study completedNCT00238147
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Washington 18
Testing effectiveness (Phase 2)Study completedNCT02843581
What this trial is testing

Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer

Who this might be right for
Metastatic Esophageal Cancer
Fuda Cancer Hospital, Guangzhou 60
Early research (Phase 1)Not Yet RecruitingNCT07814248
What this trial is testing

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)HNSCCEndometrial+5 more
TwoStep Therapeutics, Inc. 74
Not applicableStudy completedNCT02752126
What this trial is testing

Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus

Who this might be right for
Non-Small Cell Lung Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 90
Large-scale testing (Phase 3)Looking for participantsNCT07221149
What this trial is testing

Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Who this might be right for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Bristol-Myers Squibb 690
Testing effectiveness (Phase 2)Study completedNCT05355168
What this trial is testing

Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma

Who this might be right for
Toxicity, Drug
Anhui Provincial Hospital 35
Testing effectiveness (Phase 2)Looking for participantsNCT06173986
What this trial is testing

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07519486
What this trial is testing

Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Sichuan University 118
Early research (Phase 1)Study completedNCT03792347
What this trial is testing

Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hecheng Li M.D., Ph.D 20
Next Page